SCHEMBL16152083

SCHEMBL16152083

Cn1nccc1Oc1cc(Sc2ccccc2)cnc1Nc1nc(C(O)CO)ns1

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 20/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16152076 0.93 GCK (0.41) GCK
SCHEMBL16152080 0.89 GCK (0.43) GCK
SCHEMBL16152081 0.88 GCK (0.37) GCK
SCHEMBL16152079 0.87 GCK (0.54) GCK
SCHEMBL16152066 0.87 GCK (0.45) GCK
SCHEMBL16152068 0.86 GCK (0.42) GCK
SCHEMBL15202915 0.84 GCK (0.52) GCK
SCHEMBL2658178 0.84 GCK (0.52) GCK
SCHEMBL16152070 0.83 SCN9A (0.33) GCK
SCHEMBL10297595 0.83 GCK (0.51) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853409-B2 Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus ARRAY BIOPHARMA INC. (US) 2014-10-07 — — US disclosed
Send feedback